VDP
Dược phẩm Trung ương VIDIPHA ·HOSE ·2026Q1
▼ Under pressure
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, VDP is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side — margins have been compressing consistently over multiple periods. What remains unclear is whether the business can stabilize before this trend deepens.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 195.9 | 156.8 | 358.6 | 225.1 | 210.3 | 307.7 | 213.5 | 225.5 | 201.5 | 289.4 | 213.9 | 245.8 |
| Growth | +25% | -56% | +59% | +7% | -32% | +44% | -5% | +12% | -30% | +35% | -13% | — |
| Net Income | 11.9 | 19.5 | 12.0 | 18.2 | 14.1 | 23.4 | 15.6 | 15.6 | 17.6 | 20.9 | 11.6 | 27.6 |
| Net Margin | 6.08% | 12.45% | 3.34% | 8.06% | 6.72% | 7.62% | 7.29% | 6.94% | 8.71% | 7.23% | 5.40% | 11.21% |
Drivers of VDP's profit
Net profit attributable to parent declined vs last year, mainly due to higher selling expenses. Supporting and offsetting drivers:
Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE fell from 9.2% to 8.1% — leverage weakened the most, though asset turnover still provided support.
Is the profit sustainable?
Margins narrowed but earnings quality remains clean — pressure is mainly operational.
What is driving the margin?
Net margin narrowed to 6.58%, falling 0.6pp. The main pressure is SG&A / Revenue rose 2.1pp, outweighing the improvement in Gross margin rose 2.1pp (in addition, Net financial result / Revenue rose 0.1pp added support while Other profit / Revenue fell 0.5pp remained a drag).
The pressure comes from non-core items while core operations hold their rhythm — margin has a basis to recover once this factor passes.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Evaluate capital, asset, and working-capital efficiency.
Is capital being deployed efficiently?
ROIC stands at 8.28%, broadly flat versus the same period. That translates to 8.28 in after-tax operating profit for every 100 units of operating capital. NOPAT margin narrowed 0.2pp, but capital turnover rose 0.08x, with invested capital easing slightly by 70bn — the two factors are offsetting each other, keeping overall ROIC nearly unchanged.
Overall ROIC is flat while internal components are moving — watch which side becomes dominant in coming periods.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
Balance sheet is exceptionally sound — liabilities at 0.49x equity, with a net cash position equivalent to 0.09x equity.
Inventory ended the period at 283.6bn, roughly 25.4% of total assets.
Over the last 12 months, working capital released 163.3bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 9.1 days versus the same period last year. The main moves came from DIO fell 12.9 days, DSO fell 1.9 days, and DPO fell 5.6 days.
Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.
Watchpoints
CCC stands at 189.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Financial risk is low — the company has net cash and CFO reached 238.2bn.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at -0.09x and interest coverage at 6.57x.
At present, short-term debt accounts for 100.0% of total debt, cash equals 139.7% of debt, and total debt stands at 171.1bn.
Watchpoints
Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 238.2bn in 2025, against investing cash flow of -66.2bn.
Post-investment cash flow was positive +172.1bn. Financing cash flow was negative +115.0bn.
CFO / net income was 4.16x.
After spending +19.6bn on fixed-asset investment, the business generated trailing free cash flow of +236.5bn.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 190 days.
Improvement: earnings conversion looks more confirmed, with CFO / net income at 4.16x.
Key risk: working capital remains tied up for too long, with cash cycle at 189.9 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
985.6 | 934.5 | 1,019.3 | 1,007.8 | 775.5 |
|
Cost of Goods Sold
|
728.6 | 704.7 | 748.7 | 755.4 | 0.0 |
|
Gross Profit
|
257.1 | 229.7 | 270.6 | 252.4 | 178.4 |
|
Financial Expenses
|
13.5 | 17.9 | 27.6 | 24.5 | -14.4 |
|
Selling Expenses
|
95.2 | 81.5 | 120.3 | 90.1 | -72.8 |
|
General and Administrative Expenses
|
79.1 | 66.4 | 51.1 | 71.6 | -59.5 |
|
Operating Profit
|
83.7 | 84.2 | 91.2 | 92.2 | 63.2 |
|
Profit Before Tax
|
83.5 | 90.4 | 100.6 | 93.3 | 70.4 |
|
Net Income
|
63.8 | 71.8 | 80.2 | 73.5 | 55.4 |
|
Profit Attributable to Parent
|
63.8 | 71.8 | 80.2 | 73.5 | 55.4 |
|
Earnings per Share
|
2,889.00 | 3,252.00 | 4,766.00 | 4,029.00 | 3,444.39 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.